论文部分内容阅读
卵巢癌是最致命的妇科恶性肿瘤。肿瘤免疫治疗有望成为改善患者预后的重要策略。该文对肿瘤免疫机制、卵巢癌免疫治疗的现状和发展、化疗与免疫治疗的协同作用进行了阐述。
Ovarian cancer is the most deadly gynecologic malignancy. Tumor immunotherapy is expected to become an important strategy to improve the prognosis of patients. This article describes the mechanism of tumor immunity, the current status and development of immunotherapy for ovarian cancer, and the synergistic effects of chemotherapy and immunotherapy.